Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History SLGL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics SLGL

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Sol Gel Technologies Ltd

SLGL
Current price
8.02 USD +0.1 USD (+1.30%)
Last closed 8.18 USD
ISIN IL0011417206
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 22 592 512 USD
Yield for 12 month -7.04 %
1Y
3Y
5Y
10Y
15Y
SLGL
21.11.2021 - 28.11.2021

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel. Address: 7 Golda Meir Street, Ness Ziona, Israel, 7403650

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.00 USD

P/E Ratio

Dividend Yield

Financials SLGL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures SLGL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+11 538 000 USD

Last Year

+1 554 000 USD

Current Quarter

+1 031 000 USD

Last Quarter

+278 000 USD

Current Year

+11 305 000 USD

Last Year

+1 212 000 USD

Current Quarter

+1 031 000 USD

Last Quarter

EBITDA -14 165 250 USD
Operating Margin TTM -879.63 %
Price to Earnings
Return On Assets TTM -26.82 %
PEG Ratio
Return On Equity TTM -49.39 %
Wall Street Target Price 4.00 USD
Revenue TTM 12 103 000 USD
Book Value 7.24 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 121.20 %
Dividend Yield
Gross Profit TTM -9 198 000 USD
Earnings per share -4.70 USD
Diluted Eps TTM -4.70 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -107.78 %

Stock Valuation SLGL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 9.34
Enterprise Value Revenue 0.40
Price Sales TTM 1.87
Enterprise Value EBITDA 0.24
Price Book MRQ 1.02

Technical Indicators SLGL

For 52 Weeks

3.34 USD 16.50 USD
50 Day MA 7.38 USD
Shares Short Prior Month 26 269
200 Day MA 6.82 USD
Short Ratio 0.97
Shares Short 15 161
Short Percent 2.28 %